2024-10-27 04:32:53
Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice
Health/ 2023-07-22
Betagenon co-founder publishes that AMPK...

STOCKHOLM,Dec. 23,2021-- Betagenon AB,a Sweden-based company focused on development of AMPK activator compounds,today announced the publicat...

Convidecia™ Phase III Results Published in The Lancet
Corporate/ 2023-07-23
Convidecia™ Phase III Results Published...

96.0% effective against severe disease 14 days post-vaccination for population aged 18 and above. Single-dose vaccine received approvals in ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release